How Does Arynta Work for Binge Eating Disorder? The main ingredient in Arynta is lisdexamfetamine, a central nervous system (CNS) stimulant. It is not clear how lisdexamfetamine works for binge eating ...

Binge-eating disorder is the most prevalent eating disorder in the United States, but previous studies have presented conflicting views of the disorder's duration and the likelihood of relapse. A new ...

Binge eating disorder (BED) affects people of all ages, genders and ethnicities, and is the most common eating disorder in the United States. Individuals with BED repeatedly engage in excessive food ...

Binge-eating disorder is the most prevalent eating disorder in the United States, but previous studies have presented conflicting views of the disorder's duration and the likelihood of relapse. A new ...

Therapy is usually the first-line treatment if you have binge eating disorder. Vyvanse is the only FDA-approved medication ...

Prior studies have suggested that binge eating disorder may not last long, but a more rigorous look at the illness finds that just isn't so. "The big takeaway is that binge-eating disorder does ...

Binge-eating disorder (BED) is characterized by recurrent binge-eating episodes not followed by the regular use of compensatory behaviors. Research indicates a lifetime prevalence of 0.42 percent in ...

Although binge eating disorder affects millions of Americans—considerably more than bulimia or anorexia—very few seek treatment, though updated assessment and treatment guidelines aim to fix that.

Sheeran didn’t explicitly name his diagnosis, and described seeing his own experience reflected in Elton John’s memoir. “I found myself doing what Elton talks about in his book—gorging, and then it ...

Binge-eating disorder (BED) often improves with time, but full remission can take many years and relapse is common, new research suggested. The study revealed that 61% individuals still suffered from ...

Patients taking a commonly used stimulant for the treatment of binge eating disorder experienced mixed results, according to Rutgers Health researchers. Lisdexamfetamine, marketed as Vyvanse, first ...